跳至主要内容
临床试验/NCT05275036
NCT05275036招募中不适用

Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies: a Multi-center Prospective Observational Study

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 493 人开始时间: 2022年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
493
试验地点
1
主要终点
The sensitivity and specificity of early detection model for lymphoma based on cfDNA methylation or combined with other biomarkers.

研究概览

简要总结

ASCEND-LYM is a prospective, multi-center, observational study aimed at detecting early stage lymphoma and constrcuting prognostic model by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 493 participants including lymphoid malignancies and benign diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

The sensitivity and specificity of early detection model for lymphoma based on cfDNA methylation or combined with other biomarkers.

时间窗: 12 months

次要结局

  • The sensitivity and specificity of the optimal model in lymphoma patients at different clinical stages.(12 months)
  • The sensitivity and specificity of the optimal model in different subtypes of lymphoma patients.(12 months)
  • The rate of high-risk patients found by prognostic model for lymphoma based on cfDNA methylation or combined with other biomarkers.(24 months)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Huiqiang Huang

chief physician

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验